Increased expression of MMP9 was associated with poorer outcomes in nasopharyngeal carcinoma patients (55) and together with increased expression of CTHCR1 and MMP7, higher expression of MMP9 was associated with a lower survival rate after surgery in non-small cell lung cancer patients (56). Here, MMP9 is linked to non-small cell lung carcinoma.